Literature DB >> 12792009

Adverse drug event trigger tool: a practical methodology for measuring medication related harm.

J D Rozich1, C R Haraden, R K Resar.   

Abstract

Adverse drug events continue to be the single most frequent source of healthcare mishaps, continually placing patients at risk of injury. This is not unexpected, given that drug treatment is the most common medical intervention and medication use is a highly complex, multidisciplinary, and largely manual process. Assessing the actual safety of drug use has been historically difficult, mainly because traditional methods such as chart audits and voluntary reporting of data have been shown to be expensive, insensitive, and largely ineffective for detecting mistakes in drug administration and drug related adverse clinical events (ADEs). Computerized methods for detecting ADEs, employing sentinel words or "triggers" in a patient's medical record, are effective but expensive and require customized software linkage to pharmacy databases. This paper describes the use of the "trigger tool", a relatively low cost and "low tech" modification of the automated technique. The adapted technique appears to increase the rate of ADE detection approximately 50-fold over traditional reporting methodologies.

Entities:  

Mesh:

Year:  2003        PMID: 12792009      PMCID: PMC1743719          DOI: 10.1136/qhc.12.3.194

Source DB:  PubMed          Journal:  Qual Saf Health Care        ISSN: 1475-3898


  10 in total

1.  Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report.

Authors:  A K Jha; G J Kuperman; J M Teich; L Leape; B Shea; E Rittenberg; E Burdick; D L Seger; M Vander Vliet; D W Bates
Journal:  J Am Med Inform Assoc       Date:  1998 May-Jun       Impact factor: 4.497

2.  Comprehensive drug surveillance.

Authors:  H Jick; O S Miettinen; S Shapiro; G P Lewis; V Siskind; D Slone
Journal:  JAMA       Date:  1970-08-31       Impact factor: 56.272

3.  Description of a computerized adverse drug event monitor using a hospital information system.

Authors:  D C Classen; S L Pestotnik; R S Evans; J P Burke
Journal:  Hosp Pharm       Date:  1992-09

4.  Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.

Authors:  D W Bates; D J Cullen; N Laird; L A Petersen; S D Small; D Servi; G Laffel; B J Sweitzer; B F Shea; R Hallisey
Journal:  JAMA       Date:  1995-07-05       Impact factor: 56.272

5.  Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.

Authors:  D C Classen; S L Pestotnik; R S Evans; J F Lloyd; J P Burke
Journal:  JAMA       Date:  1997 Jan 22-29       Impact factor: 56.272

6.  Factors related to errors in medication prescribing.

Authors:  T S Lesar; L Briceland; D S Stein
Journal:  JAMA       Date:  1997 Jan 22-29       Impact factor: 56.272

7.  Drug-related deaths in a department of internal medicine.

Authors:  J Ebbesen; I Buajordet; J Erikssen; O Brørs; T Hilberg; H Svaar; L Sandvik
Journal:  Arch Intern Med       Date:  2001-10-22

8.  Computerized surveillance of adverse drug events in hospital patients.

Authors:  D C Classen; S L Pestotnik; R S Evans; J P Burke
Journal:  JAMA       Date:  1991-11-27       Impact factor: 56.272

9.  Relationship between medication errors and adverse drug events.

Authors:  D W Bates; D L Boyle; M B Vander Vliet; J Schneider; L Leape
Journal:  J Gen Intern Med       Date:  1995-04       Impact factor: 5.128

10.  Using a hospital information system to assess the effects of adverse drug events.

Authors:  R S Evans; D C Classen; L E Stevens; S L Pestotnik; R M Gardner; J F Lloyd; J P Burke
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1993
  10 in total
  114 in total

1.  Automated surveillance for adverse drug events at a community hospital and an academic medical center.

Authors:  Peter M Kilbridge; Udobi C Campbell; Heidi B Cozart; Maryam G Mojarrad
Journal:  J Am Med Inform Assoc       Date:  2006-04-18       Impact factor: 4.497

2.  Methodology and rationale for the measurement of harm with trigger tools.

Authors:  R K Resar; J D Rozich; D Classen
Journal:  Qual Saf Health Care       Date:  2003-12

3.  Time for a new approach to case reports.

Authors:  Riaz Agha; R David Rosin
Journal:  Int J Surg Case Rep       Date:  2010-05-04

4.  Improvement in the detection of adverse drug events by the use of electronic health and prescription records: an evaluation of two trigger tools.

Authors:  Ugochi Nwulu; Krishnarajah Nirantharakumar; Rachel Odesanya; Sarah E McDowell; Jamie J Coleman
Journal:  Eur J Clin Pharmacol       Date:  2012-06-17       Impact factor: 2.953

5.  Adverse drug reactions in a population of hospitalized very elderly patients.

Authors:  Balamurugan Tangiisuran; J Graham Davies; Juliet E Wright; Chakravarthi Rajkumar
Journal:  Drugs Aging       Date:  2012-08-01       Impact factor: 3.923

6.  Performance characteristics of a methodology to quantify adverse events over time in hospitalized patients.

Authors:  Paul J Sharek; Gareth Parry; Donald Goldmann; Kate Bones; Andrew Hackbarth; Roger Resar; Frances A Griffin; Dale Rhoda; Cathy Murphy; Christopher P Landrigan
Journal:  Health Serv Res       Date:  2010-08-16       Impact factor: 3.402

7.  Confessions of Physicians: What Systemic Reporting Does Not Uncover.

Authors:  Suzanne B Karan; Jeffrey S Berger; Michael Wajda
Journal:  J Grad Med Educ       Date:  2015-12

8.  Impact of vendor computerized physician order entry in community hospitals.

Authors:  Alexander A Leung; Carol Keohane; Mary Amato; Steven R Simon; Michael Coffey; Nathan Kaufman; Bismarck Cadet; Gordon Schiff; Eyal Zimlichman; Diane L Seger; Catherine Yoon; Peter Song; David W Bates
Journal:  J Gen Intern Med       Date:  2012-01-21       Impact factor: 5.128

9.  Quality indicators for in-hospital pharmaceutical care of Dutch elderly patients: development and validation of an ACOVE-based quality indicator set.

Authors:  Peter C Wierenga; Joanna E Klopotowska; Susanne M Smorenburg; Hendrikus J van Kan; Yuma A Bijleveld; Marcel G Dijkgraaf; Sophia E de Rooij
Journal:  Drugs Aging       Date:  2011-04-01       Impact factor: 3.923

10.  E-pharmacovigilance: development and implementation of a computable knowledge base to identify adverse drug reactions.

Authors:  Antje Neubert; Harald Dormann; Hans-Ulrich Prokosch; Thomas Bürkle; Wolfgang Rascher; Reinhold Sojer; Kay Brune; Manfred Criegee-Rieck
Journal:  Br J Clin Pharmacol       Date:  2013-09       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.